Managing Pharmaceutical Laboratories and Analytical Quality Control

Turn pharmaceutical analytical quality control from a stated policy into a practice your organisation can evidence.

📍 Istanbul🗓️ 5 training days📚 4 modules🎓 Accredited certificate
5intensive training days
4scientific modules
8training sessions
32detailed points

Course Overview

In healthcare, a weakness in pharmaceutical analytical quality control is eventually paid for by a patient. Cost pressure and quality expectations on quality control are rising at the same time. Across sectors, teams that rehearse the wider health and pharmaceutical services agenda outperform teams that only plan it. It is pitched for practitioners with responsibility for pharmaceutical analytical quality control, not for observers of it. Participants gain a realistic view of what this strand of health and pharmaceutical services costs and what it returns. Sessions alternate between guided analysis of quality control and supervised application. Buying a tool rarely fixes pharmaceutical analytical quality control; the underlying capability has to be built internally first. The course gives participants a defensible structure for quality control and the judgement to adapt it. It closes by agreeing the smallest change to the wider health and pharmaceutical services agenda that would make a visible difference.

Expected Learning Outcomes

01

Build the quality indicators for pharmaceutical analytical quality control that reflect patient outcome, not activity.

02

Agree the first three actions on quality control that will be taken on returning to work.

03

Define the scope and boundaries of pharmaceutical analytical quality control so that responsibility for it is unambiguous.

04

Adapt recognised practice on quality control to local constraints without hollowing it out.

05

Apply root cause analysis to adverse events involving pharmaceutical analytical quality control.

06

Plan staffing and rota cover appropriate to demand in quality control.

07

Plan continuity of pharmaceutical analytical quality control during surge, outbreak and emergency.

Who Should Attend

01

Quality and patient safety officers monitoring pharmaceutical analytical quality control.

02

Managers in small and medium organisations who own quality control alongside other duties.

03

Project and programme managers whose delivery depends on pharmaceutical analytical quality control.

04

Finance managers costing services delivered through quality control.

05

Nursing managers and clinical supervisors delivering pharmaceutical analytical quality control.

06

Health information and records staff supporting quality control.

Course Modules

01

Pharmaceutical analytical quality control: medication and treatment safety

2 sessions · 8 points

Session 1Auditing pharmaceutical analytical quality control at the bedside, not in the binder

  • Define escalation criteria for deterioration detected through pharmaceutical analytical quality control.
  • Match staffing levels on quality control to measured demand across the week.
  • Reduce unwarranted variation in pharmaceutical analytical quality control between shifts and sites.
  • Audit quality control by observing practice, not by reading policy.

Session 2What has to be agreed before work on quality control starts

  • Agree the smallest change to pharmaceutical analytical quality control that would be visibly useful.
  • Draft the minimum viable clinical protocol for quality control.
  • Collect evidence on the present handling of pharmaceutical analytical quality control before proposing changes.
  • Close the loop: confirm changes to quality control improved the indicator they targeted.
02

Quality control: regulation, licensing and accreditation evidence

2 sessions · 8 points

Session 1Comparing quality control with recognised practice

  • Rehearse the briefing on pharmaceutical analytical quality control that would follow an incident.
  • Verify six months later that changes to quality control have held.
  • Name a single owner for each element of pharmaceutical analytical quality control.
  • Confirm patient data handled within quality control meets confidentiality obligations.

Session 2The decisions in quality control that cannot be delegated

  • Confirm competence and continuing development for staff delivering pharmaceutical analytical quality control.
  • Define the trigger that would require quality control to be redesigned.
  • Select quality indicators for pharmaceutical analytical quality control that measure outcome rather than activity.
  • Set out how exceptions to quality control are requested and approved.
03

Quality control: supply, cold chain and availability

2 sessions · 8 points

Session 1Choosing indicators for quality control that reflect outcome

  • Apply structured root cause analysis to the last adverse event involving pharmaceutical analytical quality control.
  • Write down the assumptions underpinning the approach to quality control.
  • Measure patient experience of pharmaceutical analytical quality control and feed it back to the team.
  • Establish the boundary of quality control and record what sits outside it.

Session 2The evidence assessors will ask for on pharmaceutical analytical quality control

  • Verify cold chain and storage conditions for materials used in pharmaceutical analytical quality control.
  • Confirm that contractual obligations around quality control are understood.
  • Confirm licensing and regulatory requirements applying to pharmaceutical analytical quality control are met.
  • Confirm the incident reporting route for quality control is quick and non-punitive.
04

Quality control: incident reporting, investigation and learning

2 sessions · 8 points

Session 1Designing quality control so it helps rather than obstructs care

  • Prepare the response for the most likely failure in pharmaceutical analytical quality control.
  • Identify infection transmission risks created by quality control and control them.
  • Check that consent processes within pharmaceutical analytical quality control are genuinely informed.
  • Rank the weaknesses in quality control by consequence rather than by ease of fixing.

Session 2Making incident reporting on quality control safe for staff

  • Set out the decisions in pharmaceutical analytical quality control that require sign-off and by whom.
  • Set the review interval for quality control and who attends.
  • Identify the data already collected that bears on pharmaceutical analytical quality control.
  • Assemble the accreditation evidence pack for quality control.

Choose the package that suits you

Silver Package

At least 3 people

USD1,250
  • Workshop or Program Participation
  • Airport Transfers
  • Customized Badge
  • Expert Mentorship (Private Sessions)
  • Supervision & Secretarial Services
  • Accredited Certificate of Participation
  • Complete Training Kit
  • Coffee Break
  • Closing Ceremony

Gold Package

At least 3 people

USD1,850
  • 5-night stay in a 5-star hotel
  • Workshop or Program Participation
  • Airport Transfers
  • Customized Badge
  • Expert Mentorship (Private Sessions)
  • Supervision & Secretarial Services
  • Accredited Certificate of Participation
  • Complete Training Kit
  • Coffee Break
  • Closing Ceremony

Complete your registration

We will contact you within one business day to confirm.